ALLYRNA Pharmaceuticals is a biotechnology company focused on the research and development of innovative small molecule drugs.
ALLYRNA Pharmaceuticals has raised $100.0M in total funding. The most recent round was Seed. The last funding was announced in August 2026.
ALLYRNA Pharmaceuticals's investors include Gaorong Capital, CAS Star, Shanghai Future Industry Fund, LYFE Capital, Shanghai Guotou Pioneer Artificial Intelligence Industry Fund.
ALLYRNA Pharmaceuticals is headquartered in Hong Kong, Hong Kong.
ALLYRNA Pharmaceuticals is a biotechnology company focused on the research and development of innovative small molecule drugs.
ALLYRNA Pharmaceuticals is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ALLYRNA Pharmaceuticals — Funding & Investors." VCBacked, August 26, 2026, https://www.vcbacked.co/company/allyrna-pharmaceuticals. Accessed September 22, 2026.
VCBacked. (2026). ALLYRNA Pharmaceuticals — Funding & Investors. Retrieved September 22, 2026, from https://www.vcbacked.co/company/allyrna-pharmaceuticals
{{cite web |title=ALLYRNA Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/allyrna-pharmaceuticals |website=VCBacked |access-date=September 22, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated